MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-13-2025
VolitionRx Limited ROE Ratio 2011-2026 | VNRX
Annual ROE Ratio VolitionRx Limited
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 109.44 | 457.27 | 1188.29 | -152.29 | - | -113.39 | -148.34 | -148.32 | -56.22 | -157.67 | -2230.85 | -545.63 | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1188.29 | -2230.85 | -163.43 |
Quarterly ROE Ratio VolitionRx Limited
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 82.1 | 93.86 | 106.48 | 113.95 | 527.76 | 914.27 | 718.46 | 548.0 | 272.9 | -416.0 | -442.11 | -536.04 | -569.95 | -328.76 | -160.14 | -74.5 | -101.11 | -93.81 | -103.83 | -93.52 | -122.97 | -125.8 | -124.13 | -88.33 | -125.2 | -132.63 | -141.18 | -113.02 | -152.11 | -154.33 | -151.28 | -107.52 | -123.95 | -101.29 | -80.44 | -42.13 | -91.15 | -123.73 | -140.75 | -113.22 | -1714.06 | -3265.88 | -3013.08 | -1975.01 | -2110.99 | -646.13 | -1021.87 | -423.24 | -735.75 | -912.29 | -870.11 | -520.38 | -675.67 | -518.44 | -465.51 | -244.85 | -155.29 | -58.79 | -30.78 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 914.27 | -3265.88 | -360.26 |
ROE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-170.35 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Interpace Biosciences
IDXG
|
-302.3 | $ 1.71 | 0.73 % | $ 7.5 M |  USA |
 |
Illumina
ILMN
|
-51.54 | $ 123.79 | -0.43 % | $ 19.7 B | USA |
 |
Biomerica
BMRA
|
-121.14 | $ 2.13 | -2.74 % | $ 4.89 M | USA |
 |
Castle Biosciences
CSTL
|
4.0 | $ 25.75 | 3.0 % | $ 715 M | USA |
 |
Check-Cap Ltd.
CHEK
|
1734.41 | - | - | $ 9.42 M |  Israel |
|
Akumin
AKU
|
325.23 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Enzo Biochem
ENZ
|
-46.47 | - | -8.98 % | $ 14.8 K | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-0.85 | - | - | $ 562 M |  Britain |
 |
NeoGenomics
NEO
|
-12.91 | $ 8.1 | 1.76 % | $ 1.04 B | USA |
 |
Exact Sciences Corporation
EXAS
|
-8.66 | $ 104.91 | - | $ 19.8 B | USA |
 |
National Research Corporation
NRC
|
82.92 | $ 17.51 | 1.1 % | $ 392 M | USA |
 |
Natera
NTRA
|
-77.62 | $ 200.09 | 2.46 % | $ 19.7 B | USA |
 |
Aspira Women's Health
AWH
|
-403.65 | - | -6.19 % | $ 10.5 M | USA |
 |
Co-Diagnostics
CODX
|
-41.08 | $ 4.4 | 101.83 % | $ 129 M | USA |
 |
Accelerate Diagnostics
AXDX
|
65.62 | - | -61.36 % | $ 2.46 M | USA |
 |
OPKO Health
OPK
|
1.03 | $ 1.15 | 2.68 % | $ 798 M | USA |
 |
Global Cord Blood Corporation
CO
|
10.27 | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
-38.13 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-43.4 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-181.33 | - | 0.12 % | $ 80.1 M | China |
 |
PRA Health Sciences, Inc.
PRAH
|
13.32 | - | - | $ 10.7 B | USA |
 |
Personalis
PSNL
|
-40.05 | $ 7.61 | 4.82 % | $ 451 M | USA |
 |
Charles River Laboratories International
CRL
|
-4.56 | $ 158.0 | 2.86 % | $ 7.83 B | USA |
 |
IQVIA Holdings
IQV
|
20.91 | $ 166.96 | 0.54 % | $ 28.7 B | USA |
 |
Lantheus Holdings
LNTH
|
21.43 | $ 75.73 | -0.92 % | $ 5.11 B | USA |
 |
Motus GI Holdings
MOTS
|
-478.86 | - | -34.28 % | $ 263 K | Israel |
 |
IDEXX Laboratories
IDXX
|
65.99 | $ 578.51 | 0.22 % | $ 46.5 B | USA |
 |
Biocept
BIOC
|
-362.16 | - | -13.05 % | $ 7.29 M | USA |
 |
Invitae Corporation
NVTA
|
-98.02 | - | - | $ 21.2 M | USA |
 |
BioNano Genomics
BNGO
|
-316.66 | $ 1.46 | 26.96 % | $ 1.86 M | USA |
 |
Medpace Holdings
MEDP
|
98.27 | $ 456.93 | 0.98 % | $ 13.2 B | USA |
 |
Senseonics Holdings
SENS
|
-113.21 | $ 6.62 | 2.16 % | $ 276 M | USA |
 |
Sotera Health Company
SHC
|
12.86 | $ 13.88 | 2.81 % | $ 3.94 B | USA |
 |
Agilent Technologies
A
|
22.45 | $ 112.02 | 0.65 % | $ 34.1 B | USA |
 |
ICON Public Limited Company
ICLR
|
8.31 | $ 100.35 | 0.65 % | $ 8.28 B |  Irlanda |
 |
Soleno Therapeutics
SLNO
|
4.64 | $ 31.72 | -4.52 % | $ 1.61 B | USA |
 |
DarioHealth Corp.
DRIO
|
-61.41 | $ 7.5 | -6.13 % | $ 29.9 M | Israel |
 |
Guardant Health
GH
|
419.18 | $ 84.9 | -0.33 % | $ 10.6 B | USA |
 |
Myriad Genetics
MYGN
|
-99.43 | $ 4.66 | 1.75 % | $ 432 M | USA |
 |
Psychemedics Corporation
PMD
|
-62.26 | - | -1.84 % | $ 15.3 M | USA |
 |
Neuronetics
STIM
|
-174.27 | $ 1.6 | 10.34 % | $ 106 M | USA |
 |
QIAGEN N.V.
QGEN
|
2.34 | - | - | $ 10.6 B |  Niderland |
 |
Mettler-Toledo International
MTD
|
-3677.41 | $ 1 239.07 | 2.87 % | $ 25.5 B |  Schweiz |
 |
CareDx, Inc
CDNA
|
-7.05 | $ 17.56 | 2.39 % | $ 936 M | USA |
 |
ENDRA Life Sciences
NDRA
|
-449.46 | $ 3.48 | 0.87 % | $ 1.87 M | USA |
 |
Thermo Fisher Scientific
TMO
|
12.55 | $ 478.12 | 0.79 % | $ 180 B | USA |
 |
Celcuity
CELC
|
-96.68 | $ 106.75 | 0.67 % | $ 4.21 B | USA |
 |
Chembio Diagnostics
CEMI
|
-130.86 | - | 0.22 % | $ 16.8 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
10.17 | $ 264.42 | 0.54 % | $ 22 B | USA |